SCHEMBL6929130

SCHEMBL6929130

O=S(=O)(CCc1cccc(F)c1F)CCc1cccc(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 2/20 0.40
TAAR1 Q96RJ0 3/20 0.38
CES2 O00748 1/20 0.36
BCHE P06276 1/20 0.36
CES1 P23141 1/20 0.36
RIPK1 Q13546 1/20 0.36
CXCR2 P25025 4/20 0.35
KEAP1 Q14145 1/20 0.34
PKM P14618 1/20 0.33
PKLR P30613 1/20 0.33
MAOB P27338 1/20 0.33
AKR1C3 P42330 1/20 0.33
RECQL P46063 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
PTGES2 Q9H7Z7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL777184 0.85 AKR1B1 (0.40) AKR1B1KMT2AMEN1ALDH1A1LMNA
SCHEMBL6926904 0.83 TAAR1 (0.56) AKR1B1KMT2AMEN1ALDH1A1LMNA
SCHEMBL7052559 0.80 TAAR1 (0.48) AKR1B1LMNATAAR1CES2BCHE
SCHEMBL13466803 0.78 RIPK1 (0.40) AKR1B1KMT2AMEN1ALDH1A1LMNA
SCHEMBL5610129 0.77 TAAR1 (0.41) AKR1B1LMNATAAR1CES2BCHE
SCHEMBL777720 0.74 TAAR1 (0.50) KMT2AMEN1ALDH1A1LMNATAAR1
SCHEMBL14378228 0.74 AKR1B1 (0.48) AKR1B1KMT2AMEN1ALDH1A1LMNA
SCHEMBL14426956 0.74 ALDH1A1 (0.47) AKR1B1KMT2AMEN1ALDH1A1LMNA
SCHEMBL2210035 0.74 TAAR1 (0.67) TAAR1MAOB
SCHEMBL17748504 0.74 TAAR1 (0.48) AKR1B1TAAR1CES2BCHECES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1112251-B1 AZETIDINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM AVENTIS PHARMA SA (FR) 2003-05-07 EP disclosed
US-6518264-B2 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders AVENTIS PHARMA S.A. (FR) 2003-02-11 US disclosed
EP-1112251-A1 AZETIDINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2001-07-04 EP disclosed
WO-2000015609-A1 AZETIDINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM AVENTIS PHARMA S.A. (FR) 2000-03-23 WO disclosed